Year archive

Clover Biopharmaceuticals, Ltd. — 2023 filings

All 41 regulatory filings released by Clover Biopharmaceuticals, Ltd. (2197) in 2023, sourced directly from the official regulator.

41 Filings

2023 Period

2023 filings (41)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT - CLOVER ANNOUNCES POSITIVE PHASE I RESULTS FOR SCB-219M FOR TREATMENT OF CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) Regulatory Filings	2023-12-29	English
GRANT OF EXTENSION OF WAIVER FROM STRICT COMPLIANCE WITH RULE 14A.53 OF THE LISTING RULES UNDER THE LICENSE AGREEMENT Regulatory Filings	2023-12-27	English
VOLUNTARY ANNOUNCEMENT - CLOVER INITIATES PHASE I CLINICAL TRIAL FOR RSV VACCINE CANDIDATE Regulatory Filings	2023-12-13	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended November 30, 2023 Share Issue/Capital Change	2023-12-05	English
VOLUNTARY ANNOUNCEMENT - CLOVER COMPLETES BLA SUBMISSION FOR SEASONAL INFLUENZA VACCINE IN BRAZIL Regulatory Filings	2023-11-07	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended October 31, 2023 Regulatory Filings	2023-11-02	English
(Revised)Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2023 Regulatory Filings	2023-11-02	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2023 Share Issue/Capital Change	2023-10-09	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS Report Publication Announcement	2023-09-15	English
2023 Interim Report Interim / Quarterly Report	2023-09-15	English
VOLUNTARY ANNOUNCEMENT - CLOVER LAUNCHES QUADRIVALENT SEASONAL INFLUENZA VACCINE IN MAINLAND CHINA Regulatory Filings	2023-09-12	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended August 31, 2023 Share Issue/Capital Change	2023-09-05	English
VOLUNTARY ANNOUNCEMENT INTENTION OF DIRECTOR TO INCREASE SHAREHOLDING IN THE COMPANY Director's Dealing	2023-08-23	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023 AND CHANGE IN USE OF PROCEEDS Interim / Quarterly Report	2023-08-23	English
POSITIVE PROFIT ALERT Regulatory Filings	2023-08-14	English
DATE OF BOARD MEETING Regulatory Filings	2023-08-08	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended July 31, 2023 Regulatory Filings	2023-08-03	English
INSIDE INFORMATION - CLOVER PROVIDES UPDATES ON BUSINESS AND R&D PIPELINE DEVELOPMENT Regulatory Filings	2023-07-11	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended June 30, 2023 Regulatory Filings	2023-07-05	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended May 31, 2023 Share Issue/Capital Change	2023-06-05	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 30, 2023 AND UPDATE ON THE GRANT OF OPTIONS AND RSUS Declaration of Voting Results & Voting Rights Announcements	2023-05-30	English
VOLUNTARY ANNOUNCEMENT - CLOVER EXPANDS SALES AND DISTRIBUTION NETWORK FOR UPCOMING QUADRIVALENT SEASONAL INFLUENZA VACCINE LAUNCH IN CHINA Regulatory Filings	2023-05-24	English
CHANGE OF VENUE OF ANNUAL GENERAL MEETING AGM Information	2023-05-15	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS Report Publication Announcement	2023-05-05	English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING AGM Information	2023-05-05	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2023-05-05	English
(1). PROPOSED GRANT OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2). PROPOSED GRANT OF OPTIONS AND RSUS; (3). PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (4). AGM Information	2023-05-05	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended April 30, 2023 Regulatory Filings	2023-05-05	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS Report Publication Announcement	2023-04-20	English
2022 Annual Report Regulatory Filings	2023-04-20	English
GRANT OF OPTIONS PURSUANT TO THE POST-IPO SHARE OPTION PLAN AND GRANT OF RSUS PURSUANT TO THE RSU SCHEME Capital/Financing Update	2023-04-11	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended March 31, 2023 Regulatory Filings	2023-04-04	English
CHANGE OF JOINT COMPANY SECRETARY Board/Management Information	2023-03-31	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022 Annual Report	2023-03-29	English
DATE OF BOARD MEETING Regulatory Filings	2023-03-16	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended February 28, 2023 Regulatory Filings	2023-03-03	English
INSIDE INFORMATION - CLOVER ENTERS INTO EXCLUSIVE AGREEMENT TO COMMERCIALIZE QUADRIVALENT SEASONAL INFLUENZA VACCINE IN MAINLAND CHINA Capital/Financing Update	2023-02-20	English
VOLUNTARY ANNOUNCEMENT - CLOVER LAUNCHES COVID-19 BOOSTER VACCINE IN THE PEOPLE'S REPUBLIC OF CHINA Regulatory Filings	2023-02-14	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2023 Regulatory Filings	2023-02-03	English
INSIDE INFORMATION - CLOVER PROVIDES UPDATES ON COVID-19 VACCINE COMMERCIAL LAUNCH AND STRATEGIC PRIORITIES IN 2023 Regulatory Filings	2023-01-16	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2022 Share Issue/Capital Change	2023-01-04	English